Theriva Biologics, Inc.
TOVX
$1.42
$0.00780.55%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.61M | 16.41M | 16.59M | 18.26M | 23.18M |
| Total Receivables | 3.32M | 2.00M | 1.93M | 1.91M | 1.94M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 984.00K | 763.00K | 979.00K | 1.12M | 1.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 365.00K | 359.00K | 213.00K | 364.00K | 1.12M |
| Total Current Assets | 16.28M | 19.53M | 19.72M | 21.66M | 27.40M |
|
|
|||||
| Total Current Assets | 16.28M | 19.53M | 19.72M | 21.66M | 27.40M |
| Net Property, Plant & Equipment | 1.54M | 1.74M | 1.86M | 2.01M | 2.18M |
| Long-term Investments | -- | -- | 1.47M | 5.57M | 5.70M |
| Goodwill | -- | -- | 1.47M | 5.57M | 5.70M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.53M | 18.83M | 19.36M | 19.49M | 19.94M |
| Total Assets | 35.35M | 40.11M | 42.39M | 48.73M | 55.22M |
|
|
|||||
| Total Accounts Payable | 859.00K | 756.00K | 935.00K | 571.00K | 770.00K |
| Total Accrued Expenses | 4.51M | 5.05M | 4.46M | 3.99M | 4.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 600.00K | 606.00K | 575.00K | 560.00K | 550.00K |
| Total Finance Division Other Current Liabilities | 1.61M | 916.00K | 880.00K | 886.00K | 906.00K |
| Total Other Current Liabilities | 1.61M | 916.00K | 880.00K | 886.00K | 906.00K |
| Total Current Liabilities | 7.59M | 7.32M | 6.85M | 6.01M | 6.74M |
|
|
|||||
| Total Current Liabilities | 7.59M | 7.32M | 6.85M | 6.01M | 6.74M |
| Long-Term Debt | 92.00K | 98.00K | 93.00K | 159.00K | 162.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 873.00K | 1.04M | 1.16M | 1.30M | 1.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.74M | 7.02M | 6.64M | 7.14M | 7.18M |
| Total Liabilities | 16.29M | 15.47M | 14.74M | 14.61M | 15.52M |
|
|
|||||
| Common Stock & APIC | 355.50M | 355.34M | 349.70M | 346.70M | 346.54M |
| Retained Earnings | -334.97M | -330.53M | -322.80M | -314.48M | -309.32M |
| Treasury Stock & Other | -1.47M | -176.00K | -997.00K | -825.00K | -256.00K |
| Total Common Equity | 19.07M | 24.64M | 25.90M | 31.39M | 36.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 1.75M | 2.73M | 2.73M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 1.75M | 2.73M | 2.73M |
|
|
|||||
| Total Common Equity | 19.07M | 24.64M | 25.90M | 31.39M | 36.96M |
| Total Preferred Equity | -- | -- | 1.75M | 2.73M | 2.73M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.07M | 24.64M | 27.65M | 34.12M | 39.70M |
|
|
|||||